NO983238D0 - Exodus kjemokin materialer og fremgangsmater - Google Patents

Exodus kjemokin materialer og fremgangsmater

Info

Publication number
NO983238D0
NO983238D0 NO983238A NO983238A NO983238D0 NO 983238 D0 NO983238 D0 NO 983238D0 NO 983238 A NO983238 A NO 983238A NO 983238 A NO983238 A NO 983238A NO 983238 D0 NO983238 D0 NO 983238D0
Authority
NO
Norway
Prior art keywords
materials
methods
exodus
chemokine
exodus chemokine
Prior art date
Application number
NO983238A
Other languages
English (en)
Other versions
NO983238L (no
Inventor
Robert Hromas
Original Assignee
Indiana University Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indiana University Foundation filed Critical Indiana University Foundation
Publication of NO983238D0 publication Critical patent/NO983238D0/no
Publication of NO983238L publication Critical patent/NO983238L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO983238A 1996-11-15 1998-07-14 Exodus kjemokin materialer og fremgangsmÕter NO983238L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74951396A 1996-11-15 1996-11-15
PCT/US1997/020662 WO1998021330A1 (en) 1996-11-15 1997-11-14 Exodus chemokine materials and methods

Publications (2)

Publication Number Publication Date
NO983238D0 true NO983238D0 (no) 1998-07-14
NO983238L NO983238L (no) 1998-09-15

Family

ID=25014053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983238A NO983238L (no) 1996-11-15 1998-07-14 Exodus kjemokin materialer og fremgangsmÕter

Country Status (14)

Country Link
US (1) US6096300A (no)
EP (1) EP0894134A1 (no)
JP (1) JP2001516203A (no)
CN (1) CN1213401A (no)
AU (1) AU5255398A (no)
BR (1) BR9707142A (no)
CA (1) CA2242384A1 (no)
CZ (1) CZ220298A3 (no)
HU (1) HUP0000316A2 (no)
IL (1) IL125351A0 (no)
NO (1) NO983238L (no)
PL (1) PL327853A1 (no)
SK (1) SK96398A3 (no)
WO (1) WO1998021330A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458349B1 (en) * 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
AU741330B2 (en) * 1997-04-30 2001-11-29 F. Hoffmann-La Roche Ag Rat ST38.2 chemokine
US20030144225A1 (en) * 2001-12-28 2003-07-31 Karras James G. Antisense modulation of macrophage inflammatory protein 3-alpha expression
US6649158B1 (en) 1998-10-15 2003-11-18 Canji, Inc. Methods and compositions to induce antitumor response
WO2000022124A2 (en) * 1998-10-15 2000-04-20 Canji, Inc. Methods and compositions to induce antitumor response
WO2002032927A2 (en) * 2000-10-19 2002-04-25 Genaissance Pharmaceuticals, Inc. Haplotypes of the scya20 gene
CA2484121A1 (en) * 2002-05-01 2003-11-13 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
EP2640744A4 (en) 2010-11-19 2014-05-28 Eisai R&D Man Co Ltd NEUTRALIZATION OF ANTIBODIES TO CCL20

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037630A (en) * 1985-01-14 1991-08-06 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
US5413778A (en) * 1992-10-05 1995-05-09 The Regents Of The University Of Michigan Labelled monocyte chemoattractant protein material and medical uses thereof
AU708903B2 (en) * 1994-08-23 1999-08-12 Human Genome Sciences, Inc. Human chemokine polypeptides
US5602008A (en) * 1994-11-29 1997-02-11 Incyte Pharmaceuticals, Inc. DNA encoding a liver expressed chemokine
JP2000514295A (ja) * 1996-07-05 2000-10-31 シェーリング コーポレイション 哺乳動物のケモカイン試薬

Also Published As

Publication number Publication date
CZ220298A3 (cs) 1999-01-13
EP0894134A1 (en) 1999-02-03
NO983238L (no) 1998-09-15
JP2001516203A (ja) 2001-09-25
BR9707142A (pt) 1999-12-28
US6096300A (en) 2000-08-01
AU5255398A (en) 1998-06-03
WO1998021330A1 (en) 1998-05-22
CA2242384A1 (en) 1998-05-22
HUP0000316A2 (en) 2000-07-28
PL327853A1 (en) 1999-01-04
SK96398A3 (en) 1999-04-13
CN1213401A (zh) 1999-04-07
IL125351A0 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
IS4481A (is) Díhýdrópyramídín og notkun þeirra
DK0915880T3 (da) Azolotriaziner og pyrimidiner
NO983981D0 (no) Isolert vegg og tilhörende komponenter
NO984354D0 (no) Avisingsmiddel og anvendelse av dette
NO992297L (no) FremgangsmÕte og nye forbindelser
NO20011821D0 (no) Arbeidsromorganisering og möbelsystem
DE69734367D1 (de) Plattenstruktur und Reibschweissverfahren
DK0804078T3 (da) Sammensætning og anvendelse deraf
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
NO983238D0 (no) Exodus kjemokin materialer og fremgangsmater
NO955138D0 (no) Aktivert smektittleire, og fremstilling derav
NO984861D0 (no) Piperidiner og pyrrolidiner
NO964541L (no) Porphacyanin og CNC-utvidete porphyriner
NO985806L (no) Kitinasematerialer og fremgangsmÕter
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
DE69515383T2 (de) Abtast- und Halteschaltung
NO983556L (no) Formulering og anvendelse
FR2865535B1 (fr) Penetreur
FR2749049B1 (fr) Embrayage modulaire et sa structure
NO964581D0 (no) Regenerator, spesielt for peiser og lignende
FI931759A0 (fi) Kuorinta- ja haketuslaite
NO952766L (no) Opplösningsmiddelsammensetninger og metoder
DK1042286T3 (da) Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder
DE59812220D1 (de) Halte- und trageband

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application